IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,823,481 | -26.6% | 15,174,000 | -22.9% | 0.07% | -33.0% |
| Q2 2023 | $20,183,573 | +58.1% | 19,674,000 | +55.2% | 0.10% | +53.8% |
| Q1 2023 | $12,763,623 | -48.6% | 12,674,000 | -44.1% | 0.06% | -64.1% |
| Q4 2022 | $24,842,201 | +7.3% | 22,674,000 | 0.0% | 0.18% | +29.3% |
| Q3 2022 | $23,142,000 | -6.4% | 22,674,000 | 0.0% | 0.14% | +15.7% |
| Q2 2022 | $24,715,000 | -8.3% | 22,674,000 | 0.0% | 0.12% | +63.5% |
| Q1 2022 | $26,948,000 | +97.7% | 22,674,000 | +90.5% | 0.07% | +221.7% |
| Q4 2021 | $13,629,000 | – | 11,903,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAMDEN ASSET MANAGEMENT L P /CA | 40,225,000 | $40,854,000 | 1.37% |
| Wellesley Asset Management | 15,287 | $15,583,000 | 1.10% |
| SSI INVESTMENT MANAGEMENT LLC | 4,671,000 | $4,738,000 | 0.32% |
| WOLVERINE ASSET MANAGEMENT LLC | 21,495,000 | $21,916,000 | 0.24% |
| SHENKMAN CAPITAL MANAGEMENT INC | 3,206,000 | $3,255,000 | 0.18% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 22,674,000 | $23,142,000 | 0.14% |
| AQR Arbitrage LLC | 4,100,000 | $4,185,000 | 0.09% |
| Polar Asset Management Partners Inc. | 7,000,000 | $7,164,000 | 0.09% |
| Calamos Advisors LLC | 9,500,000 | $9,722,000 | 0.04% |
| PUTNAM INVESTMENTS LLC | 7,105,000 | $7,216,000 | 0.01% |